News

 RadNet Unveils DeepHealth, a Pioneering AI-Powered Health Informatics Portfolio November 27, 2023 by Quantib LOS ANGELES, Nov. 27, 2023 -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective outpatient diagnostic imaging ... Read Post
Arthur Post Uiterweer, CEO of Quantib, to pursue a new adventure as of October 1st October 02, 2023 by Quantib Rotterdam, The Netherlands, October 2nd, 2023 – Today marks an important day for our team as we say goodbye to Arthur Post Uiterweer, Quantib’s CEO, ... Read Post
Experts highlight the importance of introducing advanced neuroradiology tools for the diagnosis of Alzheimer's disease September 21, 2023 by Quantib Rotterdam, The Netherlands; Rome, Italy, September 21st, 2023 – Today, Rome marked World Alzheimer's Day with an event focused on cognitive decline, ... Read Post
RadNet’s Quantib B.V. Subsidiary Receives FDA Clearance for its Quantib Prostate™ 3.0 Software May 01, 2023 by Quantib Rotterdam, The Netherlands; Los Angeles, Calif., April 28, 2023 – RadNet, Inc., (NASDAQ: RDNT) today announced that it has received FDA clearance for ... Read Post
Quantib to be a partner of the European COMFORT project April 05, 2023 by Quantib The COMFORT project is a new interdisciplinary research endeavour set out to improve the health and well-being of people affected by prostate and ... Read Post
Wiro Niessen becomes the new Dean of the Faculty of Medical Sciences of the University of Groningen February 01, 2023 by Quantib Per 1st of February 2023, Wiro Niessen, Founder and Scientific lead of Quantib, has become the new Dean of the Faculty of Medical Sciences of the ... Read Post
Quantib partners up with Bayer to accelerate patient access to AI in radiology November 24, 2022 by Quantib Quantib® Prostate, our AI software for prostate MRI reading, will also be available within Bayer’s CalanticTM Digital Solutions platform. This ... Read Post
RadNet AI Subsidiaries, DeepHealth and Quantib, Obtain FDA Clearance for Mammography and Prostate AI Tools May 16, 2022 by Quantib Cambridge, Mass.; Rotterdam, The Netherlands; Los Angeles, Calif., May 13, 2022 – RadNet, Inc., (NASDAQ: RDNT) today announced that it has received ... Read Post
Radnet to acquire Quantib January 24, 2022 by Quantib RadNet to acquire Quantib and Aidence, taking giant leap in the expansion of its AI technology The two acquisitions provide RadNet with the basis for ... Read Post
Quantib launches ND 2.0 January 18, 2022 by Quantib Rotterdam, The Netherlands – Quantib, a market leader in artificial intelligence solutions for radiology, released a significant upgrade of their ... Read Post
Quantib launches Node 2.4.0 November 17, 2021 by Quantib Rotterdam, The Netherlands – Quantib, a market leader in artificial intelligence solutions for precision diagnosis, announced the significant upgrade ... Read Post
Quantib launches Quantib® Prostate 1.3 October 12, 2021 by Quantib Rotterdam, The Netherlands – October 12, 2021 – Quantib, a market leader in artificial intelligence solutions for precision diagnosis, announced ... Read Post
Quantib names Quirine van Voorst COO September 03, 2021 by Quantib Quirine van Voorst has been named Chief Operating Officer of Quantib effective September 1, 2021. Rudolf Scholte, founder and former COO of Quantib, ... Read Post
Quantib obtains CE mark for their AI prostate solution April 08, 2021 by Ory Six Rotterdam, The Netherlands – April 6, 2021 – Quantib, a market leader in artificial intelligence solutions for precision diagnosis, announced today ... Read Post
Quantib joins Precision Medicine for more Oxygen (P4O2) consortium February 25, 2021 by Jolanta Leonaite We are proud to announce that we officially started the consortium "Precision Medicine for more Oxygen" (P4O2) that aims to fundamentally improve the ... Read Post
The University of Brescia announces the installation of Quantib® ND Plus January 14, 2021 by Jolanta Leonaite Brescia, Italy | Rotterdam, The Netherlands | January 14, 2021 Today, the Department of Medical and Surgical Specialties, Radiological Sciences, and ... Read Post
Quantib receives its 6th FDA clearance for their AI prostate solution October 21, 2020 by Ory Six The FDA clearance, obtained with a record period of 41 days, marks the first time a comprehensive AI prostate solution will be available to ... Read Post
Quantib Secures FDA Clearance of Its AI Workflow Integration Platform July 09, 2020 by Ory Six The FDA clearance, Quantib’s 5th to date, further establishes the company as a leader in AI radiology solutions in the U.S. market. The news comes as ... Read Post
Quantib Selected for €2.1 Million EIC Accelerator Grant June 30, 2020 by Ory Six The grant comes from the €80 billion Horizon 2020 fund, the EU’s largest, which aims to back ‘breakthrough discoveries.’ Quantib’s promising prostate ... Read Post
Quantib releases Quantib® ND Plus: a significant update of AI radiology software for neurodegenerative diseases May 12, 2020 by Ory Six ROTTERDAM, THE NETHERLANDS, May 12th, 2020 - Quantib, market leader in artificial intelligence solutions for radiology, released an upgrade of their ... Read Post
Previous Next

    SUBSCRIBE FOR UPDATES

    Posts by Topic

    Recent Posts

    ©2025 DeepHealth